Literature DB >> 15054376

Vaccine-preventable pediatric postmeningitic sensorineural hearing loss in southern India.

Shilpa Reddy Cherukupally1, Roland Eavey.   

Abstract

OBJECTIVE: The study goal was to assess vaccine-preventable pediatric postmeningitic sensorineural hearing loss in southern India. STUDY DESIGN AND
SETTING: We conducted a prospective pilot study from January through March 2001 in a tertiary pediatric hospital in southern India.
RESULTS: Sixty-five patients were studied. Thirty-five (54%) patients had positive cerebrospinal fluid cultures, with the most common organisms being Streptococcus pneumoniae and Haemophilus influenzae. An additional 10 (15%) patients were diagnosed with tuberculous meningitis. Of 28 patients who could comply with audiometric evaluations, 8 (28%) had sensorineural hearing loss.
CONCLUSIONS: The etiologic organisms of bacterial meningitis in this study population are similar to those organisms in the developed world, with the minority exception of tuberculous meningitis. Further, a similar prevalence of postmeningitic sensorineural hearing loss occurred. SIGNIFICANCE: An effective vaccination program against S. pneumoniae and H. influenzae type b should reduce the prevalence of sensorineural hearing loss due to bacterial meningitis in developing countries with similar bacterial profiles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15054376     DOI: 10.1016/j.otohns.2003.11.017

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.

Authors:  Andrew D Clark; Ulla K Griffiths; Syed Shahid Abbas; Krishna D Rao; Lois Privor-Dumm; Rana Hajjeh; Hope Johnson; Colin Sanderson; Mathuram Santosham
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

Review 2.  Meningococcal disease in Asia: an under-recognized public health burden.

Authors:  A Vyse; J M Wolter; J Chen; T Ng; M Soriano-Gabarro
Journal:  Epidemiol Infect       Date:  2011-04-15       Impact factor: 2.451

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.